Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Max Drawdown (5Y): 74.12% for Aug. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
August 31, 2024 | 74.12% |
July 31, 2024 | 74.12% |
June 30, 2024 | 74.12% |
May 31, 2024 | 74.12% |
April 30, 2024 | 74.12% |
March 31, 2024 | 74.12% |
February 29, 2024 | 74.12% |
January 31, 2024 | 74.12% |
December 31, 2023 | 74.12% |
November 30, 2023 | 74.12% |
October 31, 2023 | 74.12% |
September 30, 2023 | 74.12% |
August 31, 2023 | 74.12% |
July 31, 2023 | 74.12% |
June 30, 2023 | 74.12% |
May 31, 2023 | 74.12% |
April 30, 2023 | 74.12% |
March 31, 2023 | 74.12% |
February 28, 2023 | 74.12% |
January 31, 2023 | 74.12% |
December 31, 2022 | 74.12% |
November 30, 2022 | 74.12% |
October 31, 2022 | 74.12% |
September 30, 2022 | 74.12% |
August 31, 2022 | 74.12% |
Date | Value |
---|---|
July 31, 2022 | 74.12% |
June 30, 2022 | 74.12% |
May 31, 2022 | 74.12% |
April 30, 2022 | 66.68% |
March 31, 2022 | 66.68% |
February 28, 2022 | 66.68% |
January 31, 2022 | 55.98% |
December 31, 2021 | 51.41% |
November 30, 2021 | 51.41% |
October 31, 2021 | 51.41% |
September 30, 2021 | 51.41% |
August 31, 2021 | 51.41% |
July 31, 2021 | 51.41% |
June 30, 2021 | 51.41% |
May 31, 2021 | 51.41% |
April 30, 2021 | 51.41% |
March 31, 2021 | 51.41% |
February 28, 2021 | 51.41% |
January 31, 2021 | 51.41% |
December 31, 2020 | 51.41% |
November 30, 2020 | 51.41% |
October 31, 2020 | 51.41% |
September 30, 2020 | 51.41% |
August 31, 2020 | 51.41% |
July 31, 2020 | 51.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
51.41%
Minimum
Sep 2019
74.12%
Maximum
May 2022
62.85%
Average
66.68%
Median
Feb 2022
Max Drawdown (5Y) Benchmarks
Novo Nordisk AS | 23.65% |
Eli Lilly and Co | 22.48% |
Altimmune Inc | 99.85% |
Genmab AS | 48.99% |
Viking Therapeutics Inc | 89.26% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 26.98 |
Beta (5Y) | 0.956 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 58.73% |
Historical Sharpe Ratio (5Y) | 0.6815 |
Historical Sortino (5Y) | 1.293 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.57% |